Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) 1
MED13L syndrome
Description
MED13L syndrome is a developmental disorder characterized by developmental delay,
intellectual disability, and minor differences in facial features. Additionally, some people
with this condition have recurrent seizures (epilepsy) or heart abnormalities that are
present from birth (congenital heart defects).
Intellectual disability and developmental delay are usually moderate to severe in people
with MED13L syndrome. Weak muscle tone (hypotonia) and delayed development of
motor skills, such as sitting, standing, and walking, are early symptoms of the condition.
After learning to walk, some affected individuals continue to have difficulty with
coordination and balance (ataxia). Speech is also delayed, and most people with this
condition develop only a few words or never learn to talk. People with MED13L
syndrome may exhibit characteristics typical of autism spectrum disorder, including
repetitive actions and difficulty with social interactions.
Most people with MED13L syndrome have unusual facial features that consist of a
depressed nasal bridge, a bulbous nasal tip, straight eyebrows, outside corners of the
eyes that point upward (upslanting palpebral fissures), full cheeks, and an open mouth.
Other facial features that sometimes occur are a pronounced double curve of the upper
lip (Cupid's bow), and a deep space between the nose and upper lip (philtrum).
Different congenital heart defects can occur in MED13L syndrome. Affected individuals
may have transposition of the great arteries, which is abnormal positioning of the large
blood vessel that distributes blood from the heart to the rest of the body (aorta) and the
artery that carries blood from the heart to the lungs (the pulmonary artery). Other
congenital heart defects in MED13L syndrome include a hole between the two lower
chambers of the heart (ventricular septal defect), a hole between the two upper
chambers of the heart (patent foramen ovale), or a particular combination of heart
defects known as tetralogy of Fallot.
Frequency
MED13L syndrome is a rare disorder that occurs in an estimated 1.6 per 100,000
newborns. More than 65 affected individuals have been reported in the scientific
literature.
Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) 2
Causes
As its name suggests, MED13L syndrome is caused by mutations in a gene known as
MED13L. This gene provides instructions for making a protein that helps regulate gene
activity; it is thought to play an essential role in development both before and after birth.
The MED13L gene mutations that cause this condition alter the function of the MED13L
protein or reduce the amount of protein present, impairing normal control of gene
activity. It is unclear how these changes lead to the particular developmental and
physical features of MED13L syndrome.
Learn more about the gene associated with MED13L syndrome
MED13L
Inheritance
MED13L syndrome is inherited in an autosomal dominant pattern, which means one
copy of the altered MED13L gene in each cell is sufficient to cause the disorder. Most
cases of this condition result from new (de novo) mutations in the gene that occur
during the formation of reproductive cells (eggs or sperm) or in early embryonic
development. These cases occur in people with no history of the disorder in their family.
Very rarely, the condition is inherited from a parent with mosaicism. In these instances,
the parent has a MED13L gene mutation in a small number of cells, including
reproductive cells (eggs or sperm), and does not show any signs or symptoms of
MED13L syndrome.
Other Names for This Condition
Asadollahi-Rauch syndrome
ASRAS
Cardiac anomalies-developmental delay-facial dysmorphism syndrome
Developmental delay-facial dysmorphism syndrome due to MED13L deficiency
Intellectual disability and distinctive facial features with or without cardiac defects
MED13L haploinsufficiency syndrome
MED13L-related intellectual disability
MRFACD
Additional Information & Resources
Genetic Testing Information
Genetic Testing Registry: Cardiac anomalies - developmental delay - facial
dysmorphism syndrome (https://www.ncbi.nlm.nih.gov/gtr/conditions/C4225208/)
Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) 3
Genetic and Rare Diseases Information Center
MED13L haploinsufficiency syndrome (https://rarediseases.info.nih.gov/diseases/12
999/index)
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD) (https://rarediseases.org/)
Catalog of Genes and Diseases from OMIM
IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL
FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD (https://omim.org
/entry/616789)
Scientific Articles on PubMed
PubMed (https://pubmed.ncbi.nlm.nih.gov/?term=%28%28MED13L+syndrome%5B
TIAB%5D%29+OR+%28MED13L%5BTI%5D%29%29+AND+english%5Bla%5D+A
ND+human%5Bmh%5D+AND+%22last+3600+days%22%5Bdp%5D)
References
Asadollahi R, Oneda B, Sheth F, Azzarello-Burri S, Baldinger R, Joset P, LatalB,
Knirsch W, Desai S, Baumer A, Houge G, Andrieux J, Rauch A. Dosage changes
ofMED13L further delineate its role in congenital heart defects and
intellectualdisability. Eur J Hum Genet. 2013 Oct;21(10):1100-4. doi: 10.1038/ejhg.
2013.17.Epub 2013 Feb 13. Citation on PubMed (https://pubmed.ncbi.nlm.nih.gov/2
3403903) or Free article on PubMed Central (https://www.ncbi.nlm.nih.gov/pmc/articl
es/PMC3778355/)
Asadollahi R, Zweier M, Gogoll L, Schiffmann R, Sticht H, Steindl K, Rauch A.
Genotype-phenotype evaluation of MED13L defects in the light of a noveltruncating
and a recurrent missense mutation. Eur J Med Genet. 2017Sep;60(9):451-464. doi:
10.1016/j.ejmg.2017.06.004. Epub 2017 Jun 21. Citation on PubMed (https://pubme
d.ncbi.nlm.nih.gov/28645799)
Cafiero C, Marangi G, Orteschi D, Ali M, Asaro A, Ponzi E, Moncada A,Ricciardi S,
Murdolo M, Mancano G, Contaldo I, Leuzzi V, Battaglia D, Mercuri E,Slavotinek AM,
Zollino M. Novel de novo heterozygous loss-of-function variants inMED13L and
further delineation of the MED13L haploinsufficiency syndrome. Eur JHum Genet.
2015 Nov;23(11):1499-504. doi: 10.1038/ejhg.2015.19. Epub 2015 Feb 25. Citation
on PubMed (https://pubmed.ncbi.nlm.nih.gov/25712080) or Free article on PubMed
Central (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613466/)
Smol T, Petit F, Piton A, Keren B, Sanlaville D, Afenjar A, Baker S, BedoukianEC,
Bhoj EJ, Bonneau D, Boudry-Labis E, Bouquillon S, Boute-Benejean O, Caumes R,
Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) 4
Chatron N, Colson C, Coubes C, Coutton C, Devillard F, Dieux-Coeslier A,Doco-
Fenzy M, Ewans LJ, Faivre L, Fassi E, Field M, Fournier C, Francannet C,
Genevieve D, Giurgea I, Goldenberg A, Green AK, Guerrot AM, Heron D, Isidor B,
Keena BA, Krock BL, Kuentz P, Lapi E, Le Meur N, Lesca G, Li D, Marey I, MignotC,
Nava C, Nesbitt A, Nicolas G, Roche-Lestienne C, Roscioli T, Satre V, SantaniA,
Stefanova M, Steinwall Larsen S, Saugier-Veber P, Picker-Minh S, Thuillier C,
Verloes A, Vieville G, Wenzel M, Willems M, Whalen S, Zarate YA, Ziegler A,
Manouvrier-Hanu S, Kalscheuer VM, Gerard B, Ghoumid J. MED13L-
relatedintellectual disability: involvement of missense variants and delineation of
thephenotype. Neurogenetics. 2018 May;19(2):93-103. doi: 10.1007/s10048-018-
0541-0.Epub 2018 Mar 6. Citation on PubMed (https://pubmed.ncbi.nlm.nih.gov/295
11999)
van Haelst MM, Monroe GR, Duran K, van Binsbergen E, Breur JM, Giltay JC,
vanHaaften G. Further confirmation of the MED13L haploinsufficiency syndrome.
Eur JHum Genet. 2015 Jan;23(1):135-8. doi: 10.1038/ejhg.2014.69. Epub 2014 Apr
30. Citation on PubMed (https://pubmed.ncbi.nlm.nih.gov/24781760) or Free article
on PubMed Central (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266749/)
Yamamoto T, Shimojima K, Ondo Y, Shimakawa S, Okamoto N.
MED13Lhaploinsufficiency syndrome: A de novo frameshift and recurrent
intragenicdeletions due to parental mosaicism. Am J Med Genet A. 2017 May;173(5):
1264-1269.doi: 10.1002/ajmg.a.38168. Epub 2017 Mar 29. Citation on PubMed (http
s://pubmed.ncbi.nlm.nih.gov/28371282)
Last updated May 1, 2019